NCT04763538

Brief Summary

Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Sep 2021

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Sep 2021Apr 2028

First Submitted

Initial submission to the registry

February 16, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2028

Expected
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

4.7 years

First QC Date

February 16, 2021

Last Update Submit

March 9, 2023

Conditions

Urologic Diseases

Outcome Measures

Primary Outcomes (1)

  • Disease specific primary endpoint

    Neuronal networks will be trained to define the respective endpoints for the diseases

    4-5 years

Interventions

Standard of careOTHER

Patients are treated according to the standard of care for each individual disease.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Entire patient population that is treated at the study sites

You may qualify if:

  • All patients treated at the study sites, signed informed consent

You may not qualify if:

  • No consent to record medical history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Roland Seiler

Biel, 2501, Switzerland

NOT YET RECRUITING

Department of Urology, Hospital Center Biel

Biel, Switzerland

RECRUITING

MeSH Terms

Conditions

Urologic Diseases

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Roland Seiler, Prof.

    Department of Urology, University Hospital Bern

    STUDY CHAIR

Central Study Contacts

Roland Seiler, Prof.

CONTACT

+41316321349Roland.Seiler@insel.ch

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2021

First Posted

February 21, 2021

Study Start

September 1, 2021

Primary Completion

April 30, 2026

Study Completion (Estimated)

April 30, 2028

Last Updated

March 10, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

In this trial, the investigators will record complete patient data in our multilayered databases. They will be used to train neuronal networks. Latter can be shared with researchers, the multilayered databases will not be shared.

Locations

CH(2)